Cookies & Privacy

We use essential cookies to make our site work. With your permission, we’ll also use analytics and marketing cookies to improve your experience. You can change your choice anytime.

See our Privacy Policy for details.

Manage preferences
Cookie preferences
Back to Industry News
Medtech

B. Riley Files 10-K, But Nasdaq Listing Remains at Risk

Summary generated with AI, editor-reviewed
Heartspace News Desk
Source: Bloomberg.com

Key takeaways

  • has submitted its delayed audited financial results for 2024, but will not meet the September 29 deadline for filing its quarterly reports this year, according to a Bloomberg report
  • This development jeopardizes the company's listing on the Nasdaq stock exchange
  • In a filing with the U
B. Riley Financial Inc. has submitted its delayed audited financial results for 2024, but will not meet the September 29 deadline for filing its quarterly reports this year, according to a Bloomberg report. This development jeopardizes the company's listing on the Nasdaq stock exchange. In a filing with the U.S. Securities and Exchange Commission, B. Riley informed Nasdaq staff that it would be unable to submit the required quarterly reports by the deadline. Nasdaq had previously stipulated that the company must complete all outstanding filings – its annual Form 10-K and the first and second-quarter 10-Qs for the current year – to maintain its listing.

Related Topics

B. Riley FinancialNasdaq listing10-K filingregulatory compliancefinancial reporting

Share Your Thoughts

(0 comments)

Be the first to share your thoughts on this article!

Stay Updated

Create alertsRead original